Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rosuvastatin calcium (ZD4522) , a selective and competitive inhibitor of hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, has antilipidemic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 34.00 | |
50 mg | In stock | $ 47.00 | |
100 mg | In stock | $ 84.00 | |
200 mg | In stock | $ 129.00 | |
500 mg | In stock | $ 216.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 29.00 |
Description | Rosuvastatin calcium (ZD4522) , a selective and competitive inhibitor of hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, has antilipidemic activity. |
Targets&IC50 | HMG-CoA:11 nM |
In vitro | In streptozotocin-induced diabetic rats, daily administration of Rosuvastatin (20 mg/kg) significantly reduces the content of very low-density lipoprotein (VLDL) within the body. Similarly, in male beagles with normal cholesterol levels, Rosuvastatin (3 mg/kg) effectively lowers the concentration of cholesterol in the plasma. |
In vivo | In isolated rat hepatocytes (IC50=1.12 nM), Rosuvastatin acts as a high-affinity substrate for OATP-C, inhibiting cholesterol synthesis. Additionally, in endothelial cells, Rosuvastatin suppresses the expression and protein levels of ICAM-1, MCP-1, IL-8, IL-6, and COX-2 mRNA by inhibiting the c-Jun N-terminal kinase and nuclear factor-kB. |
Synonyms | ZD 4522 Calcium, ZD4522, Rosuvastatin hemicalcium |
Molecular Weight | 1001.14 |
Formula | 2(C22H27FN3O6S)Ca |
CAS No. | 147098-20-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (199.77 mM), Heating is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rosuvastatin calcium 147098-20-2 Autophagy Membrane transporter/Ion channel Metabolism Potassium Channel HMG-CoA Reductase gene ZD 4522 Calcium lipoprotein Inhibitor ZD-4522 ZD4522 potential repolarization QTc Hsp70 related HMG-CoA Reductase (HMGCR) inhibit durations Rosuvastatin cholesterol hERG cardiac ZD 4522 low-density KcsA Rosuvastatin hemicalcium triglycerides action APDs inhibitor